fullerene c60 has been researched along with acrylamide in 1 studies
| Studies (fullerene c60) | Trials (fullerene c60) | Recent Studies (post-2010) (fullerene c60) | Studies (acrylamide) | Trials (acrylamide) | Recent Studies (post-2010) (acrylamide) |
|---|---|---|---|---|---|
| 3,806 | 5 | 2,170 | 3,454 | 2 | 1,625 |
| Protein | Taxonomy | fullerene c60 (IC50) | acrylamide (IC50) |
|---|---|---|---|
| Fibroblast growth factor receptor 4 | Homo sapiens (human) | 0.938 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Igisu, H; Sumizawa, T | 1 |
1 other study(ies) available for fullerene c60 and acrylamide
| Article | Year |
|---|---|
Suppression of acrylamide toxicity by carboxyfullerene in human neuroblastoma cells in vitro.
Topics: Acrylamide; Antineoplastic Agents; Buthionine Sulfoximine; Carboxylic Acids; Caspase 3; Cell Line, Tumor; Cell Survival; Cytoprotection; Dose-Response Relationship, Drug; Fullerenes; G1 Phase; Glutathione; Humans; L-Lactate Dehydrogenase; Nanoparticles; Neuroblastoma; Neurons; Particle Size | 2009 |